Frontlight ResearchEarly access
Trial site
Southeast Renal Research Institute
- 2running trials
- 3closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Chronic kidney disease5 trials
- Type 2 diabetes2 trials
- Coronary artery disease1 trial
- High blood pressure1 trial
- Peripheral artery disease1 trial
- Phase
- Phase 23 trials
- Phase 2/31 trial
- Phase 31 trial
- Status
- Completed2 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Boehringer Ingelheim1 trial
- CSL Behring1 trial
- Mineralys Therapeutics Inc.1 trial
- Novo Nordisk A/S1 trial
- Regeneron Pharmaceuticals1 trial
Running trials
Not yet recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease2 recruiting
- Coronary artery disease1 recruiting
- Peripheral artery disease1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Recruiting
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026